| abstract |
Disclosed are infant formulas comprising, on an as-fed basis (A) at ieast about 5 mg/L of gangiioskfes, (B) at least about 150 mg/L of phospholipids, (C) Jactoferrin, and (D) at (east about 70 mg/L of sialic acid, with at feast about 2.5% by weight of the sialic acid as lipid-bound sialic acid. From about 50% to 100% by weight of each of the ganglosides, phospholipids, factoferrin, and sialic acid is provided by an enriched whey protein concentrate, with the concentrate representing at least about 6.5 g/L of the formula on an asfed basis. Also disclosed are methods of using the formula to reduce the risk of diarrhea infants, and to produce a gut microflora profile similar to that of breast-fed infants. |